MedPath

Bisfosfonaattien vaikutus luuntiheyteen ja luun uusiutumiseen leikkauksen jälkeen primaarissa hyperparatyreoosissa. - PHPT ja osteoporoosi

Conditions
Potilailla on primaari hyperparatyreoosi ja osteoporoosi. Hyperparatyreoosin hoidoksi on suunniteltu leikkaushoitoa.
MedDRA version: 9.1Level: LLTClassification code 10020707Term: Hyperparathyroidism primary
Registration Number
EUCTR2008-005405-20-FI
Lead Sponsor
Department of Medicine, Helsinki University Central Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Authorised-recruitment may be ongoing or finished
Sex
All
Target Recruitment
80
Inclusion Criteria

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Not provided

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Main Objective: ;Secondary Objective: ;Primary end point(s):
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath